MICROCAPSULES PREPARED THROUGH INTERFACIAL CROSS-LINKING OF STARCH DERIVATIVES

被引:31
作者
LEVY, MC
ANDRY, MC
机构
关键词
Carboxymethylstarch; Gelatin; Human serum albumin; Hydroxyethylstarch; Interfacial cross-linking process; Microencapsulation; Salicylate;
D O I
10.1016/0378-5173(90)90028-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An interfacial cross-linking process was applied to hydrosoluble starch derivatives: hydroxyethylstarch (HES) and carboxymethylstarch (CMS). It resulted in stable microcapsules, which could be easily lyophilized and gave free-flowing powders. Sodium salicylate was encapsulated in HES microcapsules. In vitro dissolution studies indicated that these walls allow a prolonged release of the tracer. CMS microcapsules exhibited hydrophilic properties, as shown by water-induced swelling and gel formation. All cross-linked polysaccharide microcapsules were characterized by a total resistance to digestive media. However, when a protein, human serum albumin (HSA) or gelatin, was added to the starch derivatives in the aqueous phase, the process provided biodegradable microcapsules. © 1990.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 18 条
[1]   NEW TOPICAL AGENT (DEBRISAN) FOR EARLY TREATMENT OF BURNED HAND [J].
ARTURSON, G ;
HAKELIUS, L ;
JACOBSSON, S ;
ROTHMAN, U .
BURNS, 1978, 4 (04) :225-232
[2]   BIODEGRADABLE MICROSPHERES .5. STIMULATION OF MACROPHAGES WITH MICROPARTICLES MADE OF VARIOUS POLYSACCHARIDES [J].
ARTURSSON, P ;
ARRO, E ;
EDMAN, P ;
ERICSSON, JLE ;
SJOHOLM, I .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (02) :127-133
[3]   SEMIPERMEABLE MICROCAPSULES [J].
CHANG, TMS .
SCIENCE, 1964, 146 (364) :524-&
[4]  
DEASY PB, 1984, MICROENCAPSULATION R
[5]   INVITRO CYTOTOXIC ACTIVITY OF CROSS-LINKED PROTEIN MICROCAPSULES [J].
DESOIZE, B ;
JARDILLIER, JC ;
KANOUN, K ;
GUERIN, D ;
LEVY, MC .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1986, 38 (01) :8-13
[6]  
EDMAN P, 1980, J PHARM SCI-US, V69, P838, DOI 10.1002/jps.2600690725
[7]  
GOLDBERG EP, 1984, MICROSPHERES DRUG TH, P309
[8]  
GOURDIER B, 1983, 3EME ACT C INT TECH, V3, P195
[9]  
GUERIN D, 1983, INNOV TECH BIOL MED, V4, P24
[10]  
LEVY M C, 1986, 4TH P INT C PHARM TE, V3, P214